Insulin Resistance in Glucose Disposal and Production in Man with Specific Reference to Metabolic Syndrome and Type 2 Diabetes

Insulin Resistance: Insulin Action and Its Disturbances in Disease

Volumn , Issue , 2005, Pages 155-178

  Beck Nielsen, Henning ^a   Alford, Frank ^b   Hother Nielsen, Ole ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Euglycaemic clamp technique; Glucose transport; Glycogen synthesis; HOMA test (homeostasis assessment model); Insulin resistance insulin sensitivity; Insulin action cascade; IVGTT technique; Metabolic syndrome; Skeletal muscle metabolic pathways; Type 2 diabetes (T2D)

Indexed keywords

EID: 33645229598     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470011327.ch6     Document Type: Chapter

References (106)

1. Freychet, P., Roth, J. and Neville, D. M., Jr. (1971) Insulin receptors in the liver: specific binding of (125 I) insulin to the plasma membrane and its relation to insulin bioactivity. Proc Natl Acad Sci USA 68, 1833-1837.
2. Himsworth, H. P. and Kerr, R. B. (1939) Insulin-sensitive and insulin insensitive types of diabetes mellitus. Clin Sci 4, 119-152.
3. Yalow, R. S. and Berson, S. A. (1960) Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determinations by a new sensitive immuno-assay technic. Diabetes 9, 254-260.
4. Ferrannini, E. (1998) Insulin resistance versus insulin deficiency in non-insulindependent diabetes mellitus: problems and prospects. Endocr Rev 19, 477-490.
5. Beck-Nielsen, H. and Groop, L. C. (1994) Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 94, 1714-1721.
6. Matthaei, S., Stumvoll, M., Kellerer, M. and Haring, H. U. (2000) Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 21, 585-618.
7. Reaven, G. M. (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75, 473-486.
8. Radziuk, J. (2000) Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 85, 4426-4433.
9. Wallace, T. M. and Matthews, D. R. (2002) The assessment of insulin resistance in man. Diabet Med 19, 527-534.
10. Bergman, R. N., Finegood, D. T. and Ader, M. (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6, 45-86.
11. Best, J. D., Kahn, S. E., Ader, M., Watanabe, R. M., Ni, T. C. and Bergman, R. N. (1996) Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19, 1018-1030.
12. Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C. and Palmer, J. P., et al. (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42, 1663-1672.
13. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
14. Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G. and Quon, M. J. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85, 2402-2410.
15. DeFronzo, R. A., Tobin, J. D. and Andres, R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237, E214-E223.
16. Hother-Nielsen, O., Henriksen, J. E., Holst, J. J. and Beck Nielsen, H. (1996) Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique. Metabolism 45, 82-91.
17. Scheen, A. J., Paquot, N., Castillo, M. J. and Lefebvre, P. J. (1994) How to measure insulin action in vivo. Diabetes Metab Rev 10, 151-188.
18. Landau, B. R., Wahren, J., Chandramouli, V., Schumann, W. C., Ekberg, K. and Kalhan, S. C. (1996) Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 98, 378-385.
19. Chandramouli, V., Ekberg, K., Schumann, W. C., Kalhan, S. C., Wahren, J. and Landau, B. R. (1997) Quantifying gluconeogenesis during fasting. Am J Physiol 273, E1209-E1215.
20. Ferrannini, E. (1988) The theoretical bases of indirect calorimetry: a review. Metabolism 37, 287-301.
21. Kelley, D. E. and Mandarino, L. J. (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49, 677-683.
22. Rossetti, L. and Giaccari, A. (1990) Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest 85, 1785-1792.
23. Blaak, E. E., Wagenmakers, A. J., Glatz, J. F., Wolffenbuttel, B. H., Kemerink, G. J., Langenberg, C. J., Heidendal, G. A. and Saris, W. H. (2000) Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279, E146-E154.
24. Christopher, M. J., Rantzau, C., Ward, G. M. and Alford, F. P. (1994) Impact of variable insulinemia and glycemia on in vivo glycolysis and glucose storage in dogs. Am J Physiol 266, E62-71.
25. Rossetti, L., Lee, Y. T., Ruiz, J., Aldridge, S. C., Shamoon, H. and Boden, G. (1993) Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans. Am J Physiol 265, E761-E769.
26. Del Prato, S., Bonadonna, R. C., Bonora, E., Gulli, G., Solini, A., Shank, M. and DeFronzo, R. A. (1993) Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. J Clin Invest 91, 484-494.
27. Vaag, A., Alford, F., Henriksen, F. L., Christopher, M. and Beck Nielsen, H. (1995) Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Diabetologia 38, 326-336.
28. Bergman, R. N., Ider, Y. Z., Bowden, C. R. and Cobelli, C. (1979) Quantitative estimation of insulin sensitivity. Am J Physiol 236, E667-E677.
29. Weber, K. M., Martin, I. K., Best, J. D., Alford, F. P. and Boston, R. C. (1989) Alternative method for minimal model analysis of intravenous glucose tolerance data. Am J Physiol 256, E524-E535.
30. Finegood, D. T. and Tzur, D. (1996) Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method. Am J Physiol 271, E485-E495.
31. Vicini, P., Caumo, A. and Cobelli, C. (1997) The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity. Am J Physiol 273, E1024-E1032.
32. Bergman, R. N., Prager, R., Volund, A. and Olefsky, J. M. (1987) Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79, 790-800.
33. Henriksen, J. E., Alford, F., Handberg, A., Vaag, A. and Beck Nielsen, H. (1996) Glucose processing during the intravenous glucose tolerance test. Metabolism 45, 598-605.
34. Ward, G. M., Walters, J. M., Barton, J., Alford, F. P. and Boston, R. C. (2001) Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: a new approach to the insulin compartment. Metabolism 50, 512-519.
35. Ward, G. M., Weber, K. M., Walters, I. M., Aitken, P. M., Lee, B., Best, J. D., Boston, R. C. and Alford, F. P. (1991) A modified minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in insulin-dependent diabetes. Metabolism 40, 4-9.
36. Henriksen, J. E., Alford, F., Handberg, A., Vaag, A., Ward, G. M., Kalfas, A. and Beck-Nielsen, H. (1994) Increased glucose effectiveness in normoglycemic but insulinresistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. J Clin Invest 94, 1196-1204.
37. Martin, B. C., Warram, J. H., Krolewski, A. S., Bergman, R. N., Soeldner, J. S. and Kahn, C. R. (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340, 925-929.
38. Galvin, P., Ward, G., Walters, J., Pestell, R., Koschmann, M., Vaag, A., Martin, I., Best, J. D. and Alford, F. (1992) A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabet Med 9, 921-928.
39. Anderson, R. L., Hamman, R. F., Savage, P. J., Saad, M. F., Laws, A., Kades, W. W., Sands, R. E. and Cefalu, W. (1995) Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The Insulin Resistance Atherosclerosis Study. Am J Epidemiol 142, 724-732.
40. Alberti, K. G. and Zimmet, P. Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation [see comments]. Diabet Med 15, 539-553.
41. Staehr, P., Hother-Nielsen, O., Levin, K., Holst, J. J. and Beck-Nielsen, H. (2001) Assessment of hepatic insulin action in obese type 2 diabetic patients. Diabetes 50, 1363-1370.
42. Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A. and Shulman, R. G. (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322, 223-228.
43. DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J. and Felber, J. P. (1981) The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30, 1000-1007.
44. Thiebaud, D., Jacot, E., DeFronzo, R. A., Maeder, E., Jequier, E. and Felber, J. P. (1982) The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes 31, 957-963.
45. Mandarino, L. J., Wright, K. S., Verity, L. S., Nichols, J., Bell, J. M., Kolterman, O. G. and Beck-Nielsen, H. (1987) Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism. J Clin Invest 80, 655-663.
46. Young, A. A., Bogardus, C., Wolfe Lopez, D. and Mott, D. M. (1988) Muscle glycogen synthesis and disposition of infused glucose in humans with reduced rates of insulinmediated carbohydrate storage. Diabetes 37, 303-308.
47. Thorburn, A. W., Gumbiner, B., Brechtel, G. and Henry, R. R. (1990) Effect of hyperinsulinemia and hyperglycemia on intracellular glucose and fat metabolism in healthy subjects. Diabetes 39, 22-30.
48. Yki-Jarvinen, H., Bogardus, C. and Howard, B. V. (1987) Hyperglycemia stimulates carbohydrate oxidation in humans. Am J Physiol 253, E376-E382.
49. Levin, K., Daa, S. H., Alford, F. P. and Beck-Nielsen, H. (2001) Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia 44, 824-833.
50. Damsbo, P., Vaag, A., Hother-Nielsen, O. and Beck-Nielsen, H. (1991) Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34, 239-245.
51. Højlund, K., Staehr, P., Hansen, B. F., Green, K. A., Hardie, D. G., Richter, E. A., Beck-Nielsen, H. and Wojtaszewski, J. F. (2003) Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes. Diabetes 52, 1393-1402.
52. Vaag, A., Alford, F. and Beck-Nielsen, H. (1996) Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects? Diabet Med 13, 806-815.
53. Golay, A., DeFronzo, R. A., Ferrannini, E., Simonson, D. C., Thorin, D., Acheson, K., Thiebaud, D., Curchod, B., Jequier, E. and Felber, J. P. (1988) Oxidative and nonoxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31, 585-591.
54. Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E. and DeFronzo, R. A. (1989) Glucose and free fatty acid metabolism in non-insulindependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 84, 205-213.
55. Felber, J. P., Golay, A., Felley, C. and Jequier, E. (1988) Regulation of glucose storage in obesity and diabetes: metabolic aspects. Diabetes Metab Rev 4, 691-700.
56. Thorburn, A. W., Gumbiner, B., Bulacan, F., Wallace, P. and Henry, R. R. (1990) Intracellular glucose oxidation and glycogen synthase activity are reduced in noninsulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest 85, 522-529.
57. Randle, P. J., Garland, P. B., Hales, C. N. and Newsholme, E. A. (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785-789.
58. Boden, G., Jadali, F., White, J., Liang, Y., Mozzoli, M., Chen, X., Coleman, E. and Smith, C. (1991) Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88, 960-966.
59. Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W. and Shulman, G. I. (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97, 2859-2865.
60. Kelley, D. E., Mokan, M., Simoneau, J. A. and Mandarino, L. J. (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92, 91-98.
61. Andres, R., Cadar, G. and Zierler, K. (1956) The quantitative minor role of oxidative metabolism by skeletal muscle in intact man in the basal state. J Clin Invest 35, 671-682.
62. Colberg, S. R., Simoneau, J. A., Thaete, F. L. and Kelley, D. E. (1995) Skeletal muscle utilization of free fatty acids in women with visceral obesity [see comments]. J Clin Invest 95, 1846-1853.
63. Kelley, D. E., Goodpaster, B., Wing, R. R. and Simoneau, J. A. (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277, E1130-E1141.
64. Kelley, D. E. and Simoneau, J. A. (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94, 2349-2356.
65. Shulman, G. I. (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106, 171-176.
66. Zierath, J. R., Krook, A. and Wallberg-Henriksson, H. (2000) Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43, 821-835.
67. Lund, S., Pedersen, O., Holman, G. D., Clark, A. E., Zierath, J. R. and Wallberg-Henriksson, H. (1997) GLUT4 translocation in human muscle strips. Biochem Soc Trans 25, 466S.
68. Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., Petersen, K. F. and Shulman, G. I. (1999) Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103, 253-259.
69. Krook, A., Bjornholm, M., Galuska, D., Jiang, X. J., Fahlman, R., Myers, M. G., Jr., Wallberg-Henriksson, H. and Zierath, J. R. (2000) Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49, 284-292.
70. Meyer, M. M., Levin, K., Grimmsmann, T., Beck-Nielsen, H. and Klein, H. H. (2002) Insulin signalling in human skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease. Diabetologia 45, 813-822.
71. Grimmsmann, T., Levin, K., Meyer, M. M., Beck-Nielsen, H. and Klein, H. H. (2002) Delays in insulin signaling towards glucose disposal in human skeletal muscle. J Endocrinol 172, 645-651.
72. Krook, A., Roth, R. A., Jiang, X. J., Zierath, J. R. and Wallberg-Henriksson, H. (1998) Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47, 1281-1286.
73. Gaster, M., Staehr, P., Beck-Nielsen, H., Schroder, H. D. and Handberg, A. (2001) GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes 50, 1324-1329.
74. Gaster, M., Petersen, I., Hojlund, K., Poulsen, P. and Beck-Nielsen, H. (2002) The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 51, 921-927.
75. Hother-Nielsen, O. and Beck-Nielsen, H. (1990) On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia 33, 603-610.
76. Hother-Nielsen, O. (1996) Constant tracer infusion technique for assessment of glucose turnover in vivo: current status. In: Marshall SM, Home PD, Rizza RA, eds. Diabetes Annual/10. Amsterdam: Elsevier, 301-336.
77. Radziuk, J. and Pye, S. (2002) Quantitation of basal endogenous glucose production in Type II diabetes: importance of the volume of distribution. Diabetologia 45, 1053-1084.
78. Hother-Nielsen, O. and Beck-Nielsen, H. (1991) Insulin resistance, but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus. Acta Endocrinol Copenh 124, 637-645.
79. Hother-Nielsen, O. and Beck-Nielsen, H. (1991) Basal glucose metabolism in type 2 diabetes. A critical review. Diabet Metab 17, 136-145.
80. Rigalleau, V., Beylot, M., Laville, M., Guillot, C., Deleris, G., Aubertin, J. and Gin, H. (1996) Measurement of post-absorptive glucose kinetics in non-insulin-dependent diabetic patients: methodological aspects. Eur J Clin Invest 26, 231-236.
81. Beck-Nielsen, H., Hother-Nielsen, O., Vaag, A. and Alford, F. (1994) Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment. Diabetologia 37, 217-221.
82. Beck-Nielsen, H., Hother-Nielsen, O. and Staehr, P. (2002) Is hepatic glucose production increased in Type 2 diabetes mellitus? Curr Diabetes Rep 2 (3), 231-236.
83. Vranic, M. (1992) Banting Lecture: Glucose turnover. A key to understanding the pathogenesis of diabetes (indirect effects of insulin). Diabetes 41, 1188-1206.
84. Giacca, A., Fisher, S. J., Shi, Z. Q., Gupta, R., Lickley, H. L. and Vranic, M. (1992) Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J Clin Invest 90, 1769-1777.
85. Cherrington, A. D., Edgerton, D. and Sindelar, D. K. (1998) The direct and indirect effects of insulin on hepatic glucose production in vivo. Diabetologia 41, 987-996.
86. Cherrington, A. D. (1999) Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 48, 1198-1214.
87. Hother-Nielsen, O., Henriksen, J. E., Staehr, P. and Beck-Nielsen, H. (1995) Labelled glucose infusate technique in clamp studies. Is precise matching of glucose specific activity important? Endocrinol Metab 2, 275-287.
88. Turk, D., Alzaid, A., Dinneen, S., Nair, K. S. and Rizza, R. (1995) The effects of noninsulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest 95, 755-762.
89. Edgerton, D. S., Cardin, S., Emshwiller, M., Neal, D., Chandramouli, V., Schumann, W. C., Landau, B. R., Rossetti, L. and Cherrington, A. D. (2001) Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism. Diabetes 50, 1872-1882.
90. Lewis, G. F., Carpentier, A., Vranic, M. and Giacca, A. (1999) Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes. Diabetes 48, 570-576.
91. Staehr, P., Hother-Nielsen, O., Landau, B. R., Chandramouli, V., Holst, J. J. and Beck-Nielsen, H. (2003) Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes 52, 260-267.
92. Boden, G., Cheung, P., Stein, T. P., Kresge, K. and Mozzoli, M. (2002) FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am J Physiol Endocrinol Metab 283, E12-E19.
93. Matsuda, M., DeFronzo, R. A., Glass, L., Consoli, A., Giordano, M., Bressler, P. and DelPrato, S. (2002) Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals. Metabolism 51, 1111-1119.
94. Nielsen, M. F., Wise, S., Dinneen, S. F., Schwenk, W. F., Basu, A. and Rizza, R. A. (1997) Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis. Diabetes 46, 2007-2016.
95. Shah, P., Vella, A., Basu, A., Basu, R., Schwenk, W. F. and Rizza, R. A. (2000) Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 85, 4053-4059.
96. Gastaldelli, A., Baldi, S., Pettiti, M., Toschi, E., Camastra, S., Natali, A., Landau, B. R. and Ferrannini, E. (2000) Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49, 1367-1373.
97. Gastaldelli, A., Toschi, E., Pettiti, M., Frascerra, S., Quinones-Galvan, A., Sironi, A. M., Natali, A. and Ferrannini, E. (2001) Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes 50, 1807-1812.
98. Efendic, S., Karlander, S. and Vranic, M. (1998) Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity. J Clin Invest 81, 1953-1961.
99. Paquot, N., Scheen, A. J., Dirlewanger, M., Lefebvre, P. J. and Tappy, L. (2002) Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients. Obes Res 10, 129-134.
100. Massillon, D., Barzilai, N., Hawkins, M., Prus-Wertheimer, D. and Rossetti, L. (1997) Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion [published erratum appears in Diabetes 1997 Mar; 46 (3): 536]. Diabetes 46, 153-157.
101. Clore, J. N., Stillman, J. and Sugerman, H. (2000) Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes 49, 969-974.
102. Caro, J. F., Triester, S., Patel, V. K., Tapscott, E. B., Frazier, N. L. and Dohm, G. L. (1995) Liver glucokinase: decreased activity in patients with type II diabetes. Horm Metab Res 27, 19-22.
103. Adeli, K., Taghibiglou, C., Van Iderstine, S. C. and Lewis, G. F. (2001) Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc Med 11, 170-176.
104. Taghibiglou, C., Carpentier, A., Van Iderstine, S. C., Chen, B., Rudy, D., Aiton, A., Lewis, G. F. and Adeli, K. (2000) Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 275, 8416-8425.
105. Malmstrom, R., Packard, C. J., Caslake, M., Bedford, D., Stewart, P., Yki-Jarvinen, H., Shepherd, J. and Taskinen, M. R. (1997) Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 40, 454-462.
106. Lewis, G. F., Carpentier, A., Adeli, K. and Giacca, A. (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23, 201-229.